Table 1.
Relationship between CDCA5 expression and clinicopathological feature in 201 HCC cases
| Characteristic | CDCA5 Expression Level | P-Value | |
|---|---|---|---|
| Low | High | ||
| Mean age | 58.11±9.38 | 53.80±9.09 | 0.572 |
| AFP | 0.290 | ||
| <400 | 22 | 108 | |
| ≥400 | 15 | 56 | |
| Tumor grade | 0.161 | ||
| Low and moderate | 22 | 80 | |
| High | 15 | 84 | |
| Size(cm) | 0.004** | ||
| <5 | 19 | 44 | |
| ≥5 | 18 | 120 | |
| Tumor number | 0.019*; ※ | ||
| 1 | 34 | 124 | |
| ≥2 | 3 | 40 | |
| PVTT | 0.568 | ||
| Absent | 31 | 144 | |
| Present | 6 | 20 | |
| Child-Pugh class | 0.264 | ||
| A | 27 | 108 | |
| B or C | 10 | 56 | |
| BCLC stage | 0.518 | ||
| 0 | 2 | 3 | |
| A | 12 | 52 | |
| B | 17 | 71 | |
| C | 6 | 38 | |
*(p<0.05); ** (p<0.01); ※(continuity correction); BCLC, BCLC staging system.